| P2093 | author name string | Mauro Martins Teixeira | |
| | Peter C Taylor | |
| | Robert T Schoen | |
| | J Kennedy Amaral | |
| | Thomas E Tem Morrison | |
| P2860 | cites work | Characterization of reemerging chikungunya virus | Q21090531 |
| | Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study | Q21195256 |
| | Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study | Q21562246 |
| | Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period | Q21562272 |
| | Human muscle satellite cells as targets of Chikungunya virus infection | Q21562321 |
| | Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia | Q24288818 |
| | Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages | Q24288996 |
| | Chikungunya virus infection | Q24497757 |
| | Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor | Q24625887 |
| | Type I IFN controls chikungunya virus via its action on nonhematopoietic cells | Q24647231 |
| | Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis | Q24674760 |
| | Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses | Q39649864 |
| | Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response | Q39881534 |
| | Post-chikungunya rheumatic disorders in travelers after return from the Caribbean. | Q40118411 |
| | French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. | Q40149705 |
| | Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist 6 years later | Q40166145 |
| | Cytokine levels in patients with chikungunya virus infection | Q40243475 |
| | Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus | Q40248768 |
| | The cell biology of Chikungunya virus infection | Q40283972 |
| | Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study | Q40305540 |
| | Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up. | Q40318663 |
| | A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years | Q40372969 |
| | Membrane fusion and the alphavirus life cycle | Q40551613 |
| | Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis | Q41225621 |
| | Chikungunya virus aches and pains: an emerging challenge | Q41940293 |
| | Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection | Q42923192 |
| | Post-chikungunya chronic arthralgia: a first retrospective follow-up study of 39 cases in Colombia | Q44249709 |
| | Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya | Q44843505 |
| | Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. | Q44849755 |
| | Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island | Q44851009 |
| | Ross River virus infection of human synovial cells in vitro | Q45838169 |
| | Chikungunya: vaccines and therapeutics | Q47098677 |
| | Frequency of Chronic Joint Pain following Chikungunya Infection: A Colombian Cohort Study | Q47187737 |
| | A cross-sectional analysis of chikungunya arthritis patients 22-months post-infection demonstrate no detectable viral persistence in synovial fluid | Q47265641 |
| | Lessons learned from Chikungunya in the Americas | Q47549786 |
| | Treatment of chronic chikungunya arthritis with methotrexate: a systematic review | Q47549791 |
| | Chikungunya Virus Arthritis: Implications of Acute and Chronic Inflammation Mechanisms on Patient Management | Q47559664 |
| | Chikungunya: Molecular Aspects, Clinical Outcomes and Pathogenesis | Q47562306 |
| | Vaccine and Therapeutic Options To Control Chikungunya Virus | Q47566099 |
| | The neurological complications of chikungunya virus: A systematic review. | Q54232538 |
| | A Case Report of Chikungunya Fever, Rheumatoid Arthritis, and Felty's Syndrome. | Q54256323 |
| | Chikungunya in Brazil: Rheumatologists on the Front Line | Q57058373 |
| | Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial | Q58611177 |
| | Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses | Q58801220 |
| | Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat ad | Q73574475 |
| | Successful Methotrexate Treatment of Chronic Chikungunya Arthritis | Q90302408 |
| | Seroprevalence of Asian Lineage Chikungunya Virus Infection on Saint Martin Island, 7 Months After the 2013 Emergence | Q24701720 |
| | Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection | Q24701792 |
| | The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic | Q27469278 |
| | IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity | Q27487567 |
| | Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness | Q27491022 |
| | Interleukin-17 and type 17 helper T cells | Q28256510 |
| | Caspase inhibitors: viral, cellular and chemical | Q28261303 |
| | Mosquito cellular factors and functions in mediating the infectious entry of chikungunya virus | Q28486029 |
| | Persistent RNA virus infections: do PAMPS drive chronic disease? | Q28804036 |
| | Global expansion of Chikungunya Virus: Mapping the 64 year history | Q28950696 |
| | Epidemiology of Chikungunya in the Americas | Q31147049 |
| | Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments | Q33632225 |
| | Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes | Q34000129 |
| | Species-specific impact of the autophagy machinery on Chikungunya virus infection | Q34036496 |
| | Replication cycle of chikungunya: a re-emerging arbovirus | Q34042046 |
| | Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging | Q34099818 |
| | Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 |
| | Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia | Q34222718 |
| | Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40 | Q34465628 |
| | Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. | Q34719466 |
| | Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. | Q35168183 |
| | Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in sri lanka, in 2007: a longitudinal cohort study | Q35837865 |
| | Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis | Q36114846 |
| | Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review | Q36400444 |
| | Methotrexate in rheumatoid arthritis. | Q36590429 |
| | Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms? | Q36828876 |
| | Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis | Q36964861 |
| | Chikungunya fever: an epidemiological review of a re-emerging infectious disease | Q37575480 |
| | Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy | Q38118022 |
| | Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking | Q38158924 |
| | Chikungunya fever. Rheumatic manifestations of an emerging disease in Europe | Q38246374 |
| | Chikungunya triggers an autophagic process which promotes viral replication | Q38560348 |
| | Impaired NK cell functionality and increased TNF-α production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis | Q38756018 |
| | Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis | Q38789052 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arthritis | Q170990 |
| | chikungunya | Q243257 |
| | methotrexate | Q422232 |
| | disease-modifying antirheumatic drug | Q810254 |
| | Chikungunya virus | Q15794049 |
| | infectious disease | Q18123741 |
| | RNA virus infectious disease | Q18967413 |
| P304 | page(s) | 289 | |
| P577 | publication date | 2019-03-22 | |
| P1433 | published in | Viruses | Q7935305 |
| P1476 | title | The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis | |
| P478 | volume | 11 | |